Mitchell Shawnte
SEC insider (Form 3/4/5 filer). CIK 0001749432. CHIEF LEGAL OFFICER at Olema Pharmaceuticals, Inc. (OLMA). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in SAN FRANCISCO, CA.
Companies Mitchell Shawnte has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Officer, CHIEF LEGAL OFFICER
Mitchell Shawnte
CIK: 0001749432
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Olema Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 4, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect24.8K shares at avg. $24.25$601K - Mar 4, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect233 shares at avg. $24.69$6K - Mar 4, 2026OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect25K shares at avg. $4.37$109K - Mar 3, 2026OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect15K shares at avg. $4.37$66K - Mar 3, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect15K shares at avg. $23.01$345K - Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
220K shares- - Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectPerformance Stock Options (Right to Buy)
56.3K shares- - Feb 28, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
450K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 24,767 | $24.25 | $600,600 | Direct |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 233 | $24.69 | $5,753 | Direct |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 25,000 | $4.37 | $109,250 | Direct |
| Mar 3, 2026 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 15,000 | $4.37 | $65,550 | Direct |
| Mar 3, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 15,000 | $23.01 | $345,150 | Direct |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 220,000 | - | - | Direct |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Performance Stock Options (Right to Buy) | 56,250 | - | - | Direct |
| Feb 28, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 450,000 | - | - | Direct |
1-8 of 8 transactions